Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33


The European cross-border health data exchange roadmap: Case study in the Italian setting.

Nalin M, Baroni I, Faiella G, Romano M, Matrisciano F, Gelenbe E, Martinez DM, Dumortier J, Natsiavas P, Votis K, Koutkias V, Tzovaras D, Clemente F.

J Biomed Inform. 2019 Jun;94:103183. doi: 10.1016/j.jbi.2019.103183. Epub 2019 Apr 19.


Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia.

Nicoletti F, Orlando R, Di Menna L, Cannella M, Notartomaso S, Mascio G, Iacovelli L, Matrisciano F, Fazio F, Caraci F, Copani A, Battaglia G, Bruno V.

Front Psychiatry. 2019 Feb 14;10:49. doi: 10.3389/fpsyt.2019.00049. eCollection 2019. Review.


Epigenetic Alterations in Prenatal Stress Mice as an Endophenotype Model for Schizophrenia: Role of Metabotropic Glutamate 2/3 Receptors.

Matrisciano F, Dong E, Nicoletti F, Guidotti A.

Front Mol Neurosci. 2018 Nov 30;11:423. doi: 10.3389/fnmol.2018.00423. eCollection 2018. Review.


The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice.

Meltzer HY, Rajagopal L, Matrisciano F, Hao J, Svensson KA, Huang M.

Behav Brain Res. 2019 Apr 1;361:139-150. doi: 10.1016/j.bbr.2018.12.006. Epub 2018 Dec 3.


The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders.

Bruno V, Caraci F, Copani A, Matrisciano F, Nicoletti F, Battaglia G.

Neuropharmacology. 2017 Mar 15;115:180-192. doi: 10.1016/j.neuropharm.2016.04.044. Epub 2016 Apr 30. Review.


Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review.

Matrisciano F, Panaccione I, Grayson DR, Nicoletti F, Guidotti A.

Curr Neuropharmacol. 2016;14(1):41-7. Review.


Behavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugs.

Dong E, Tueting P, Matrisciano F, Grayson DR, Guidotti A.

Transl Psychiatry. 2016 Jan 12;6:e711. doi: 10.1038/tp.2015.191.


Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice.

Dong E, Dzitoyeva SG, Matrisciano F, Tueting P, Grayson DR, Guidotti A.

Biol Psychiatry. 2015 Mar 15;77(6):589-96. doi: 10.1016/j.biopsych.2014.08.012. Epub 2014 Aug 27.


Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.

Orlando R, Borro M, Motolese M, Molinaro G, Scaccianoce S, Caruso A, di Nuzzo L, Caraci F, Matrisciano F, Pittaluga A, Mairesse J, Simmaco M, Nisticò R, Monn JA, Nicoletti F.

Neuropharmacology. 2014 Nov;86:133-44. doi: 10.1016/j.neuropharm.2014.07.009. Epub 2014 Jul 22.


L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F, Battaglia G, Mathé AA, Pittaluga A, Lionetto L, Simmaco M, Nicoletti F.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4804-9. doi: 10.1073/pnas.1216100110. Epub 2013 Feb 4.


Exposure to predator odor and resulting anxiety enhances the expression of the α2 δ subunit of voltage-sensitive calcium channels in the amygdala.

Nasca C, Orlando R, Marchiafava M, Boldrini P, Battaglia G, Scaccianoce S, Matrisciano F, Pittaluga A, Nicoletti F.

J Neurochem. 2013 Jun;125(5):649-56. doi: 10.1111/j.1471-4159.2012.07895.x. Epub 2013 Jan 8.


Enhanced mGlu5-receptor dependent long-term depression at the Schaffer collateral-CA1 synapse of congenitally learned helpless rats.

Pignatelli M, Vollmayr B, Richter SH, Middei S, Matrisciano F, Molinaro G, Nasca C, Battaglia G, Ammassari-Teule M, Feligioni M, Nisticò R, Nicoletti F, Gass P.

Neuropharmacology. 2013 Mar;66:339-47. doi: 10.1016/j.neuropharm.2012.05.046. Epub 2012 Jun 16.


mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants.

Chaki S, Ago Y, Palucha-Paniewiera A, Matrisciano F, Pilc A.

Neuropharmacology. 2013 Mar;66:40-52. doi: 10.1016/j.neuropharm.2012.05.022. Epub 2012 May 26. Review.


Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.

Matrisciano F, Tueting P, Dalal I, Kadriu B, Grayson DR, Davis JM, Nicoletti F, Guidotti A.

Neuropharmacology. 2013 May;68:184-94. doi: 10.1016/j.neuropharm.2012.04.013. Epub 2012 Apr 28.


Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.

Matrisciano F, Tueting P, Maccari S, Nicoletti F, Guidotti A.

Neuropsychopharmacology. 2012 Mar;37(4):929-38. doi: 10.1038/npp.2011.274. Epub 2011 Nov 16.


Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis.

Gavin DP, Sharma RP, Chase KA, Matrisciano F, Dong E, Guidotti A.

Neuropsychopharmacology. 2012 Jan;37(2):531-42. doi: 10.1038/npp.2011.221. Epub 2011 Nov 2. Erratum in: Neuropsychopharmacology. 2012 Aug;37(9):2173.


Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain.

Matrisciano F, Dong E, Gavin DP, Nicoletti F, Guidotti A.

Mol Pharmacol. 2011 Jul;80(1):174-82. doi: 10.1124/mol.110.070896. Epub 2011 Apr 19.


Induction of the Wnt antagonist Dickkopf-1 is involved in stress-induced hippocampal damage.

Matrisciano F, Busceti CL, Bucci D, Orlando R, Caruso A, Molinaro G, Cappuccio I, Riozzi B, Gradini R, Motolese M, Caraci F, Copani A, Scaccianoce S, Melchiorri D, Bruno V, Battaglia G, Nicoletti F.

PLoS One. 2011 Jan 27;6(1):e16447. doi: 10.1371/journal.pone.0016447.


Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P.

Neuropharmacology. 2011 Jun;60(7-8):1007-16. doi: 10.1016/j.neuropharm.2010.10.021. Epub 2010 Nov 11. Review.


Enhanced expression of the neuronal K+/Cl- cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats.

Matrisciano F, Nasca C, Molinaro G, Riozzi B, Scaccianoce S, Raggi MA, Mercolini L, Biagioni F, Mathè AA, Sanna E, Maciocco E, Pignatelli M, Biggio G, Nicoletti F.

Brain Res. 2010 Apr 14;1325:112-20. doi: 10.1016/j.brainres.2010.02.017. Epub 2010 Feb 11.


Repeated anabolic androgenic steroid treatment causes antidepressant-reversible alterations of the hypothalamic-pituitary-adrenal axis, BDNF levels and behavior.

Matrisciano F, Modafferi AM, Togna GI, Barone Y, Pinna G, Nicoletti F, Scaccianoce S.

Neuropharmacology. 2010 Jun;58(7):1078-84. doi: 10.1016/j.neuropharm.2010.01.015. Epub 2010 Feb 4.


Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE.

Mercolini L, Mandrioli R, Iannello C, Matrisciano F, Nicoletti F, Raggi MA.

Talanta. 2009 Nov 15;80(1):279-85. doi: 10.1016/j.talanta.2009.06.074. Epub 2009 Jul 8.


Regulation of group II metabotropic glutamate receptors by G protein-coupled receptor kinases: mGlu2 receptors are resistant to homologous desensitization.

Iacovelli L, Molinaro G, Battaglia G, Motolese M, Di Menna L, Alfiero M, Blahos J, Matrisciano F, Corsi M, Corti C, Bruno V, De Blasi A, Nicoletti F.

Mol Pharmacol. 2009 Apr;75(4):991-1003. doi: 10.1124/mol.108.052316. Epub 2009 Jan 22.


Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.

Matrisciano F, Caruso A, Orlando R, Marchiafava M, Bruno V, Battaglia G, Gruber SH, Melchiorri D, Tatarelli R, Girardi P, Mathè AA, Nicoletti F.

Neuropharmacology. 2008 Sep;55(4):525-31. doi: 10.1016/j.neuropharm.2008.05.014. Epub 2008 May 24.


Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruberto A, Tatarelli R, Nicoletti F, Girardi P, Shelton RC.

J Psychiatr Res. 2009 Jan;43(3):247-54. doi: 10.1016/j.jpsychires.2008.03.014. Epub 2008 Jun 3.


Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis.

Matrisciano F, Zusso M, Panaccione I, Turriziani B, Caruso A, Iacovelli L, Noviello L, Togna G, Melchiorri D, Debetto P, Tatarelli R, Battaglia G, Nicoletti F, Giusti P, Girardi P.

Neuropharmacology. 2008 Feb;54(2):428-37. Epub 2007 Nov 7.


Nanomolar concentrations of anabolic-androgenic steroids amplify excitotoxic neuronal death in mixed mouse cortical cultures.

Orlando R, Caruso A, Molinaro G, Motolese M, Matrisciano F, Togna G, Melchiorri D, Nicoletti F, Bruno V.

Brain Res. 2007 Aug 24;1165:21-9. Epub 2007 Jul 10.


Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?

Matrisciano F, Panaccione I, Zusso M, Giusti P, Tatarelli R, Iacovelli L, Mathé AA, Gruber SH, Nicoletti F, Girardi P.

Mol Psychiatry. 2007 Aug;12(8):704-6. No abstract available.


Comparative effects of levobupivacaine and racemic bupivacaine on excitotoxic neuronal death in culture and N-methyl-D-aspartate-induced seizures in mice.

Marganella C, Bruno V, Matrisciano F, Reale C, Nicoletti F, Melchiorri D.

Eur J Pharmacol. 2005 Aug 22;518(2-3):111-5.


Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.

Matrisciano F, Scaccianoce S, Del Bianco P, Panaccione I, Canudas AM, Battaglia G, Riozzi B, Ngomba RT, Molinaro G, Tatarelli R, Melchiorri D, Nicoletti F.

J Neurochem. 2005 Jun;93(5):1345-52.


Endogenous activation of group-II metabotropic glutamate receptors inhibits the hypothalamic-pituitary-adrenocortical axis.

Scaccianoce S, Matrisciano F, Del Bianco P, Caricasole A, Di Giorgi Gerevini V, Cappuccio I, Melchiorri D, Battaglia G, Nicoletti F.

Neuropharmacology. 2003 Apr;44(5):555-61.


Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus.

Matrisciano F, Storto M, Ngomba RT, Cappuccio I, Caricasole A, Scaccianoce S, Riozzi B, Melchiorri D, Nicoletti F.

Neuropharmacology. 2002 Jun;42(8):1008-15.


[The use of cysteine and acetylcysteine collyria in chemical burns of the cornea. Experimental studies].

Menna F, Antonucci R, Ippolito S, Maronne V, Matrisciano F.

Bull Mem Soc Fr Ophtalmol. 1982;94:425-8. French. No abstract available.


Supplemental Content

Loading ...
Support Center